Elligo Health Research: Miranda Mann Porter, COO
Elligo Health Research has named Miranda Mann Porter to its leadership team as COO. She brings a diverse, extensive background in therapeutics, operational execution of clinical development programs and Phase I-IV trials, post-marketing medical affairs services, and healthcare delivery.
John Potthoff, CEO of Elligo, said, “Miranda brings a wealth of experience to the COO role as we continue to build out our team and hire the best minds in the industry. We look forward to continuing to expand our leadership team, technologies, and service offerings as we further our mission to ensure that all patients have access to clinical trials as a care option.”